Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 22, 2013 (13 years ago)

Dexamethasone Opth Soln 0.1% PF

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Dexamethasone Opth Soln 0.1% PF, 10 ml Opthalmic Soln, 30 day expiration,

Drug: Dexamethasone

Recalling firm
Nora Apothecary and Alternative Therapies, Inc.
Origin
IN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-473-2013 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Dexamethasone recalls

See all
Class II · Moderate risk

Dexamethasone Sodium Phosphate Injection

Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.

Ongoing Impurity / degradation Somerset Therapeutics LLC D-0398-2026
Class II · Moderate risk

Dexonto 0.4%

Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.

Ongoing Labeling / mix-up Nubratori, Inc NDC 71300-6564-1 D-0392-2025

Other recalls by Nora Apothecary and Alternative Therapies, Inc.

All 2013 recalls
Class II · Moderate risk

Pyridoxine 100mg/ml Inj MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-495-2013
Class II · Moderate risk

Meperidine 100mg/ml MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-494-2013
Class II · Moderate risk

Lidocaine 2% Inj MDV

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-493-2013
Class II · Moderate risk

M.I.C.+B12 Inj MDV: 3x50ml

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Terminated Sterility / contamination Nora Apothecary and Alternative Therapies, Inc. D-492-2013